Morgan Stanley’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Morgan Stanley’s Portfolio NPSP Stock Details NPSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-562,047	Closed	-$20.1M	–	6885
2014 Q4	$20.1M	Buy	562,047 +28,325	+5%	+$846K	0.01%	1489
2014 Q3	$13.9M	Sell	533,722 -9,338	-2%	-$268K	0.01%	1736
2014 Q2	$17.9M	Buy	543,060 +64,209	+13%	+$1.85M	0.01%	1528
2014 Q1	$14.3M	Buy	478,851 +91,206	+24%	+$3.14M	0.01%	1661
2013 Q4	$11.8M	Sell	387,645 -344,028	-47%	-$9.47M	0.01%	1809
2013 Q3	$23.3M	Buy	731,673 +1,525	+0.2%	+$35K	0.01%	1117
2013 Q2	$11M	Buy	+730,148	New	+$10.1M	0.01%	1621

Other funds holding NPSP

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Morgan Stanley's NPSP Position: Q1 2015 in Review

Morgan Stanley sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2015, closing a stake of 562,047 shares — an estimated $20.1M sold.

Morgan Stanley first reported a position in NPSP in Q2 2013 and held it in 7 quarters. The position peaked at $23.3M in Q3 2013. 1 fund tracked by Wall St. Rank holds NPSP as of Q1 2015.

Morgan Stanley reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Morgan Stanley sold 562,047 NPS PHARMACEUTICALS INC shares in Q1 2015, an estimated $20.1M.
Morgan Stanley first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
Morgan Stanley's NPS PHARMACEUTICALS INC position peaked at $23.3M in Q3 2013.
1 fund tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2015.

Based on Morgan Stanley's 13F filing for Q1 2015, filed 14 May 2015.